Heart Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Heart Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Heart transplantation treatment for a malignant cardiac granular cell tumor: 33 months of survival.

Gualis J, Carrascal Y, de la Fuente L, Echevarría JR

Cardiac Surgery Unit, Hospital Clínico Universitario de Valladolid, Avda. Ramón y Cajal, 5 Valladolid, Spain. javgua@hotmail.com

A malignant granular cell tumor is a high-grade sarcoma with a high rate of metastasis, local recurrence and short survival. We describe a patient who underwent orthotopic heart transplantation due to a metastatic unresectable malignant granular cell tumor. At thirty-three months following this procedure she is alive and free of recurrence.

Published 21 September 2007 in Interact Cardiovasc Thorac Surg, 6(5): 679-81.
Full-text of this article is available online (may require subscription).

© 2005-2008 Heart Transplant Research Today. All Rights Reserved.